Celldex Therapeutics, Inc. Secured Debt
Celldex Therapeutics, Inc. (CLDX) had Secured Debt of $10.10 million as of 2013-03-31, per its 10-Q filed 2013-05-03.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:SecuredDebt · last filed 2013-05-03
- 2013-03-31: Secured Debt $10.10M.
- 2012-12-31: Secured Debt $11.30M.
- 2012-09-30: Secured Debt $12.60M.
- 2012-06-30: Secured Debt $13.90M.
| Period end | Secured Debt |
|---|---|
| 2013-03-31 | $10.10M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $11.30M 10-K · filed 2013-03-08 |
| 2012-09-30 | $12.60M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $13.90M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |